Gearing A J, Thorpe R
Division of Immunobiology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, U.K.
J Immunol Methods. 1988 Nov 10;114(1-2):3-9. doi: 10.1016/0022-1759(88)90145-7.
Three lyophilized preparations of interleukin-2 coded 86/500, 86/564 and 86/504 have been evaluated in an international collaborative study for their suitability as an international standard. All of the preparations performed well in the different bioassay systems included in the study, and showed excellent stability on accelerated temperature degradation. Material similar to that in preparation 86/504 has served well as an interim reference reagent for interleukin-2 for 3 years. Therefore with the agreement of the study participants and the authorization of the Expert Committee on Biological Standardization of the World Health Organization, the preparation coded 86/504 was established in 1987 as the 1st international standard for interleukin-2, with a defined potency of 100 IU/ampoule.
对三种白细胞介素 -2冻干制剂(编号分别为86/500、86/564和86/504)进行了一项国际合作研究,以评估其作为国际标准的适用性。在该研究纳入的不同生物测定系统中,所有制剂表现良好,并且在加速温度降解试验中显示出优异的稳定性。与86/504制剂类似的材料作为白细胞介素 -2的临时参考试剂已使用了3年。因此,经研究参与者同意并获得世界卫生组织生物标准化专家委员会批准,编号为86/504的制剂于1987年被确立为白细胞介素 -2的首个国际标准,每安瓿规定效价为100国际单位。